| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |